BV-3111

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameBV-3111
Drug Alias NameBV-3111
ClassificationSmall moleculesNatural product/Extract
Mechanisms of ActionImmunomodulators
TargetsUpdating
Therapy Area/IndicationsImmune System Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBioved
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBioved
Active IndicationsN/A
Inactive IndicationsImmune System Diseases

Other Information

ATC CodeN/A
Related LinksN/A